❗ Now published in The Journal of the Royal Society of Medicine (JRSM)
Twitter thread by Deepti Gurdasani
While I'm grateful that JCVI are advising vaccinating all 16-17 yrs, this delay has been costly. We're still behind vaccine policy in other countries for 12-15 yr olds. Our preprint out today shows benefits far outweigh risks for 12-17 yr olds in England🧵https://t.co/nNkCKDnSuU
— Dr. Deepti Gurdasani (@dgurdasani1) August 4, 2021
📰 Media coverage